Signant Health, a leading enabler of evidence generation for modern clinical trials, today announced the appointment of Sanjiv Waghmare as Chief Product Officer. In his new role, Waghmare will be responsible for building upon the success of Signant’s pioneering clinical research science and technology solutions with emphasis on steering roadmap strategy and optimizing core solutions…
Signant Health recently announced the appointment of Roger Smith as Chief Executive Officer. Smith succeeds John Hubbard, who served as interim CEO of Signant Health and will now become Chairman of the company. Since 2000, biopharmaceutical sponsors, biotechs, CROs and academic institutions, including all of the top 20 biopharmaceutical companies, have trusted Signant Health’s technologies…